Acesion Pharma appoints experienced clinical leader Christina Sylvest as SVP Acute Cardioversion
News
August 5, 2016
COPENHAGEN, Denmark
Acesion Pharma, a pharmaceutical company developing novel first-in-class drugs to treat atrial fibrillation (AF), announced today that it has appointed Christina Sylvest, MSc Pharm, as Senior Vice President Acute Cardioversion.
Read the news release from Acesion Pharma.